Sensex Today | Stock Market LIVE Updates: Natco Pharma has received a Warning Letter dated 8th April, 2024 from USFDA. The company said it does not believe that the warning leter will have an impact on disruption of supplies or existing revenues from this facility. It may cause delay/withholding of pending product approvals from this site.